HomeRLMD • NASDAQ
add
Relmada Therapeutics Inc
Previous close
$0.30
Day range
$0.30 - $0.33
Year range
$0.24 - $4.73
Market cap
9.83M USD
Avg Volume
383.46K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 19.08M | -28.90% |
Net income | -18.66M | 25.86% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 44.91M | -53.38% |
Total assets | 45.82M | -53.03% |
Total liabilities | 10.30M | -15.57% |
Total equity | 35.52M | — |
Shares outstanding | 33.19M | — |
Price to book | 0.25 | — |
Return on assets | -93.93% | — |
Return on capital | -114.71% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -18.66M | 25.86% |
Cash from operations | -8.80M | 14.15% |
Cash from investing | 11.35M | 46.56% |
Cash from financing | -172.49K | -75.18% |
Net change in cash | 2.37M | 191.03% |
Free cash flow | -2.29M | -57.54% |
About
Headquarters
Website
Employees
17
